Amy Johnson, Xueqin Song, Ao Hsu, Ching-Shih Chen (2001)
Apoptosis signaling pathways mediated by cyclooxygenase-2 inhibitors in prostate cancer cells.Advances in enzyme regulation, 41
G. Chan, J. Boyle, E. Yang, Fan Zhang, P. Sacks, Jatin Shah, D. Edelstein, R. Soslow, A. Koki, B. Woerner, J. Masferrer, A. Dannenberg (1999)
Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck.Cancer research, 59 5
M. Tsujii, S. Kawano, S. Tsuji, H. Sawaoko, M. Hori, R. Dubois (1998)
Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer CellsCell, 94
M. Taketo (1998)
Cyclooxygenase-2 inhibitors in tumorigenesis (Part II).Journal of the National Cancer Institute, 90 21
A. Koki, J. Masferrer (2002)
Celecoxib: a specific COX-2 inhibitor with anticancer properties.Cancer control : journal of the Moffitt Cancer Center, 9 2 Suppl
Randall Harris, S. Kasbari, W. Farrar (1999)
Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer.Oncology reports, 6 1
J. Masferrer, K. Leahy, A. Koki, B. Zweifel, S. Settle, B. Woerner, D. Edwards, A. Flickinger, R. Moore, K. Seibert (2000)
Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.Cancer research, 60 5
Sébastien Arico, S. Pattingre, C. Bauvy, P. Gane, A. Barbat, P. Codogno, E. Ogier-Denis (2002)
Celecoxib Induces Apoptosis by Inhibiting 3-Phosphoinositide-dependent Protein Kinase-1 Activity in the Human Colon Cancer HT-29 Cell Line*The Journal of Biological Chemistry, 277
I. Vivanco, C. Sawyers (2002)
The phosphatidylinositol 3-Kinase–AKT pathway in human cancerNature Reviews Cancer, 2
D. Roymans, H. Slegers (2001)
Phosphatidylinositol 3-kinases in tumor progression.European journal of biochemistry, 268 3
chih‐cheng yang, Ho-pi Lin, Chang‐Shi Chen, Ya-Ting Yang, Ping-Hui Tseng, V. Rangnekar, Ching Chen (2003)
Bcl-xL Mediates a Survival Mechanism Independent of the Phosphoinositide 3-Kinase/Akt Pathway in Prostate Cancer Cells*Journal of Biological Chemistry, 278
D. Solit, F. Zheng, M. Drobnjak, P. Münster, B. Higgins, D. Verbel, G. Heller, W. Tong, C. Cordon-Cardo, D. Agus, H. Scher, N. Rosen (2002)
17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts.Clinical cancer research : an official journal of the American Association for Cancer Research, 8 5
P. Flynn, M. Wong, M. Zavar, N. Dean, D. Stokoe (2000)
Inhibition of PDK-1 activity causes a reduction in cell proliferation and survivalCurrent Biology, 10
Christopher Williams, Alastair Watson, H. Sheng, R. Helou, J. Shao, Raymond DuBois (2000)
Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models.Cancer research, 60 21
A. Hsu, T. Ching, Dasheng Wang, Xueqin Song, V. Rangnekar, Ching-shih Chen (2000)
The Cyclooxygenase-2 Inhibitor Celecoxib Induces Apoptosis by Blocking Akt Activation in Human Prostate Cancer Cells Independently of Bcl-2*The Journal of Biological Chemistry, 275
K. Martin, S. Schalm, C. Richardson, A. Romanelli, Kristen Keon, J. Blenis (2001)
Regulation of Ribosomal S6 Kinase 2 by Effectors of the Phosphoinositide 3-Kinase Pathway*The Journal of Biological Chemistry, 276
A. Koki, N. Khan, B. Woerner, K. Seibert, J. Harmon, A. Dannenberg, R. Soslow, J. Masferrer (2002)
Characterization of cyclooxygenase-2 (COX-2) during tumorigenesis in human epithelial cancers: evidence for potential clinical utility of COX-2 inhibitors in epithelial cancers.Prostaglandins, leukotrienes, and essential fatty acids, 66 1
R. Sandler, S. Halabi, J. Baron, S. Budinger, E. Paskett, R. Keresztes, N. Petrelli, M. Pipas, D. Karp, Charles Loprinz, G. Steinbach, R. Schilsky (2003)
A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.The New England journal of medicine, 348 10
G. Steinbach, P. Lynch, R. Phillips, M. Wallace, E. Hawk, G. Gordon, Naoki Wakabayashi, B. Saunders, Yu Shen, T. Fujimura, L. Su, B. Levin, L. Godio, S. Patterson, M. Rodriguez-Bigas, Susan Jester, K. King, M. Schumacher, J. Abbruzzese, R. Dubois, W. Hittelman, Stuart Zimmerman, J. Sherman, G. Kelloff (2000)
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.The New England journal of medicine, 342 26
J. Mitchell, T. Evans (1998)
Cyclooxygenase-2 as a therapeutic targetInflammation Research, 47
D. Hwang, D. Scollard, J. Byrne, E. Levine (1998)
Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer.Journal of the National Cancer Institute, 90 6
M. Oshima, J. Dinchuk, S. Kargman, H. Oshima, Bruno Hancock, E. Kwong, J. Trzăskos, Jilly Evans, M. Taketo (1996)
Suppression of Intestinal Polyposis in Apc Δ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)Cell, 87
(2000)
Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor
Rajnish Gupta, R. Dubois (2001)
Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2Nature Reviews Cancer, 1
S. Zha, W. Gage, J. Sauvageot, E. Saria, M. Putzi, C. Ewing, D. Faith, W. Nelson, A. Marzo, W. Isaacs (2001)
Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma.Cancer research, 61 24
O. Tucker, A. Dannenberg, E. Yang, Fan Zhang, L. Teng, J. Daly, R. Soslow, J. Masferrer, B. Woerner, A. Koki, T. Fahey, Thomas Fahey (1999)
Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer.Cancer research, 59 5
L. Marnett, R. Dubois (2002)
COX-2: a target for colon cancer prevention.Annual review of pharmacology and toxicology, 42
Xueqin Song, Ho-pi Lin, A. Johnson, Ping-Hui Tseng, Ya-Ting Yang, S. Kulp, Ching Chen (2002)
Cyclooxygenase-2, player or spectator in cyclooxygenase-2 inhibitor-induced apoptosis in prostate cancer cells.Journal of the National Cancer Institute, 94 8
S. Grösch, I. Tegeder, E. Niederberger, L. Bräutigam, G. Geisslinger (2001)
COX‐2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX‐2 inhibitor celecoxibThe FASEB Journal, 15
R. Meier, M. Thelen, B. Hemmings (1998)
Inactivation and dephosphorylation of protein kinase Bα (PKBα) promoted by hyperosmotic stressThe EMBO Journal, 17
Shivapriya Ramaswamy, N. Nakamura, F. Vazquez, D. Batt, S. Perera, T. Roberts, W. Sellers (1999)
Regulation of G 1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase y Akt pathway
L. Vindeløv, I. Christensen, N. Nissen (1983)
A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis.Cytometry, 3 5
M. Rose, E. Woolf, B. Matuszewski (2000)
Determination of celecoxib in human plasma by normal-phase high-performance liquid chromatography with column switching and ultraviolet absorbance detection.Journal of chromatography. B, Biomedical sciences and applications, 738 2
S. Paulson, Todd Kaprak, Christopher Gresk, D. Fast, M. Baratta, E. Burton, A. Breau, Aziz Karim (1999)
Plasma protein binding of celecoxib in mice, rat, rabbit, dog and humanBiopharmaceutics & Drug Disposition, 20
M. Thun, M. Namboodiri, E. Calle, W. Flanders, C. Heath (1993)
Aspirin use and risk of fatal cancer.Cancer research, 53 6
B. Zweifel, T. Davis, R. Ornberg, J. Masferrer (2002)
Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.Cancer research, 62 22
R. Fujiwaki, K. Iida, H. Kanasaki, T. Ozaki, K. Hata, K. Miyazaki (2002)
Cyclooxygenase-2 expression in endometrial cancer: correlation with microvessel count and expression of vascular endothelial growth factor and thymidine phosphorylase.Human pathology, 33 2
Nicholas Pullen, P. Dennis, M. Andjelkovic, Almut Dufner, S. Kozma, B. Hemmings, George Thomas (1998)
Phosphorylation and activation of p70s6k by PDK1.Science, 279 5351
G. Harewood (1999)
Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.The New England journal of medicine, 341 18
M. Taketo (1998)
Cyclooxygenase-2 inhibitors in tumorigenesis (part I).Journal of the National Cancer Institute, 90 20
A. Johnson, A. Hsu, Ho-pi Lin, Xueqin Song, Ching-shih Chen (2002)
The cyclo-oxygenase-2 inhibitor celecoxib perturbs intracellular calcium by inhibiting endoplasmic reticulum Ca2+-ATPases: a plausible link with its anti-tumour effect and cardiovascular risks.The Biochemical journal, 366 Pt 3
Shivapriya Ramaswamy, N. Nakamura, F. Vázquez, D. Batt, S. Perera, T. Roberts, W. Sellers (1999)
Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway.Proceedings of the National Academy of Sciences of the United States of America, 96 5
C. Eberhart, R. Coffey, A. Radhika, F. Giardiello, S. Ferrenbach, R. Dubois (1994)
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas.Gastroenterology, 107 4
L. Weng, J. Brown, C. Eng (2001)
PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model.Human molecular genetics, 10 6
T. Hida, Y. Yatabe, H. Achiwa, H. Muramatsu, K. Kozaki, S. Nakamura, M. Ogawa, T. Mitsudomi, T. Sugiura, Takashi Takahashi (1998)
Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas.Cancer research, 58 17
M. Wick, Lily Dong, Ramon Riojas, Fresnida Ramos, Feng Liu (2000)
Mechanism of Phosphorylation of Protein Kinase B/Akt by a Constitutively Active 3-Phosphoinositide-dependent Protein Kinase-1*The Journal of Biological Chemistry, 275
(2004)
American Association for Cancer cancerres.aacrjournals.org Downloaded from
C. Williams, M. Tsujii, J. Reese, S. Dey, R. Dubois (2000)
Host cyclooxygenase-2 modulates carcinoma growth.The Journal of clinical investigation, 105 11
Jiuxiang Zhu, Xueqin Song, Ho-pi Lin, D. Young, Shunqi Yan, V. Marquez, Ching Chen (2002)
Using cyclooxygenase-2 inhibitors as molecular platforms to develop a new class of apoptosis-inducing agents.Journal of the National Cancer Institute, 94 23
E. Giovannucci, E. Rimm, M. Stampfer, G. Colditz, A. Ascherio, Walter Willett (1994)
Aspirin Use and the Risk for Colorectal Cancer and Adenoma in Male Health ProfessionalsAnnals of Internal Medicine, 121
J. Baron, B. Cole, R. Sandler, R. Haile, D. Ahnen, R. Bresalier, G. McKeown-Eyssen, R. Summers, R. Rothstein, C. Burke, D. Snover, T. Church, John Allen, M. Beach, G. Beck, J. Bond, T. Byers, E. Greenberg, J. Mandel, N. Marcon, L. Mott, L. Pearson, F. Saibil, R. Stolk (2003)
A randomized trial of aspirin to prevent colorectal adenomas.The New England journal of medicine, 348 10
A. González-García, E. Garrido, C. Hernández, B. Alvarez, Concepción Jiménez, D. Cantrell, N. Pullen, A. Carrera (2002)
A New Role for the p85-Phosphatidylinositol 3-Kinase Regulatory Subunit Linking FRAP to p70 S6 Kinase Activation*The Journal of Biological Chemistry, 277
T. Penning, J. Talley, S. Bertenshaw, J. Carter, P. Collins, S. Docter, M. Graneto, L. Lee, James Malecha, J. Miyashiro, R. Rogers, D. Rogier, S. Yu, G. Anderson, E. Burton, J. Cogburn, S. Gregory, C. Koboldt, W. Perkins, K. Seibert, A. Veenhuizen, Yan Zhang, P. Isakson (1997)
Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).Journal of medicinal chemistry, 40 9
Cancer Research – Unpaywall
Published: Feb 15, 2004
Access the full text.
Sign up today, get DeepDyve free for 14 days.